Prostate cancer (PC) is the most frequently diagnosed cancer and the second leading cause ... The objective of this study is to develop a dual drug conjugate with a prostate-specific antigen (PSA) ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Discover comprehensive insights into approved therapeutics and research developments targeting Prostate-Specific Membrane Antigen (PSMA). This product provides detailed competitor analysis, R&D stages ...

Search for other works by this author on: ...

Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

One of the main challenges is the scarcity of truly cancer-specific antigens for precise targeting of solid tumors. The use of engineered small, specific antigen-binding domains, such as nanobodies, ...